Compare CPIX & DFLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CPIX | DFLI |
|---|---|---|
| Founded | 1999 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electronic Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.5M | 49.0M |
| IPO Year | 2009 | N/A |
| Metric | CPIX | DFLI |
|---|---|---|
| Price | $3.85 | $2.84 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $22.50 |
| AVG Volume (30 Days) | 230.6K | ★ 632.3K |
| Earning Date | 03-03-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $41,278,349.00 | ★ $57,783,000.00 |
| Revenue This Year | N/A | $17.85 |
| Revenue Next Year | N/A | $30.29 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 12.21 | ★ 18.24 |
| 52 Week Low | $1.85 | $1.50 |
| 52 Week High | $7.25 | $26.10 |
| Indicator | CPIX | DFLI |
|---|---|---|
| Relative Strength Index (RSI) | 47.43 | 43.02 |
| Support Level | $3.54 | $2.54 |
| Resistance Level | $3.98 | $3.00 |
| Average True Range (ATR) | 0.34 | 0.33 |
| MACD | -0.07 | -0.17 |
| Stochastic Oscillator | 22.73 | 26.38 |
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
Dragonfly Energy Holdings Corp is a manufacturer of non-toxic deep cycle lithium-ion batteries that are designed to displace lead acid batteries in a number of different storage applications and end markets including RV, marine vessel, and solar and off-grid industries, with disruptive solid-state cell technology currently under development. The company's deep cycle lithium iron phosphate ("LFP") batteries provide numerous advantages compared to incumbent products, such as lead-acid batteries. LFP batteries are non-toxic and environmentally friendly, do not rely on scarce or controversial metals, and are a cost-effective storage solution.